title: Favorable outcome of a pregnancy after fampridine exposition during the first month.
authors: Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France. Electronic address: elisabeth.maillart@aphp.fr.
authors: Elisabeth
authors: E
authors: Maillart
authors: Department of Neurology, Fondation Rothschild Hospital, Paris, France.
authors: Olivier
authors: O
authors: Gout
authors: Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France.
authors: Catherine
authors: C
authors: Lubetzki
authors: Neonatal Unit, Department of Obstetrics and Gynecology, Pitié-Salpêtrière Hospital, APHP, Paris, France.
authors: Bénédicte
authors: B
authors: Carpentier
authors: Department of Obstetrics and Gynecology, Pitié-Salpêtrière Hospital, APHP, Paris, France.
authors: Jacky
authors: J
authors: Nizard
mesh_terms: D015761:4-Aminopyridine / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome
chemical_list: D026902:Potassium Channel Blockers; D015761:4-Aminopyridine
keywords: Fampridine; Multiple sclerosis; Pregnancy